evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract
13777,GENE_SUMMARY,,SF3B1 encodes a component of the spliceosome complex that is involved in mRNA processing. Mutations in SF3B1 lead to aberrant alternative splicing and altered gene expression.,,2017-04-05,,23451,SF3B1,splicing factor 3b subunit 1,True,ENST00000335508,NM_012433.2,PRP10,SAP155,Hsh155,PRPF10,SF3b155,MDS,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
13778,GENE_BACKGROUND,,"The SF3B1 (splicing factor 3b subunit 1) gene encodes a protein in the spliceosome complex that is responsible for removal of introns from messenger RNA. SF3B1 is an essential gene/protein so loss is not tolerated in cells, therefore very few if any truncating mutations or SF3B1 gene loss/deletions are observed. This complex contains snRNAs (small nuclear RNAs), snRNP (small nuclear ribonucleoprotein particles) and non-snRNP proteins. SF3B1 binds to nucleosomes to identify exon and intron junctions of coding genes (PMID: 25892229). SF3B1 also contributes to sister chromatid cohesion and chromosome segregation (PMID: 25257310). Mutations in SF3B1 are recurrent in uveal melanoma (PMID: 26842708). Additionally, mutations in SF3B1 are frequent in patients with myelodysplastic syndromes (MDS) (PMID: 21909114, 21995386), especially those with refractory anemia with ring sideroblasts (RARS) and refractory cytopenia with multilineage dysplasia and ring sideroblasts (RCMD-RS) (PMID: 21995386, 21998214). Mutations in SF3B1 lead to altered gene expression and aberrant alternative splicing (PMID: 25428262). mRNAs can become mis-spliced by use of alternative or non-canonical splice sites or may retain introns leading to altered coding sequences (PMID: 25768983, 22150006). Mutations in SF3B1 tend to occur in the C-terminal HEAT repeat region and tend to be missense mutations rather than non-sense or frameshift mutations, suggesting that either gain-of-function, dominant negative or altered function results rather than complete loss of function (PMID: 22150006, 21909114). Mutations in SF3B1 are often mutually exclusive with mutations in other splicing factor mutations, including SRSF2, U2AF1, ZRSR2, SF1, PRPF40B, U2AF2 and SF3A1 (PMID: 21909114). The SF3B complex can be inhibited by naturally occurring compounds, including spliceostatin A (PMID: 17643111), meayamycin B (PMID: 23485022) and pladienolide (PMID: 17643112).",,2017-04-05,,23451,SF3B1,splicing factor 3b subunit 1,True,ENST00000335508,NM_012433.2,PRP10,SAP155,Hsh155,PRPF10,SF3b155,MDS,False,25768983,Transcriptome sequencing reveals potential mechanism of cryptic 3' splice site selection in SF3B1-mutated cancers.,PLoS computational biology,2018-03-01T20:15:00,11,3,e1004105,DeBoever C et al,doi: 10.1371/journal.pcbi.1004105,,0001-03-01,,17643112,Splicing factor SF3b as a target of the antitumor natural product pladienolide.,Nature chemical biology,2018-09-01T20:07:00,3,9,570-5,Kotake Y et al,,,0001-09-01,,25428262,Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.,Leukemia,2018-05-01T20:15:00,29,5,1092-103,Dolatshad H et al,doi: 10.1038/leu.2014.331,,2018-05-01T01:03:00,,23485022,Chemical perturbation of Mcl-1 pre-mRNA splicing to induce apoptosis in cancer cells.,ACS chemical biology,2018-05-17T20:13:00,8,5,895-900,Gao Y et al,doi: 10.1021/cb300602j,,2018-05-17T09:00:00,,21909114,Frequent pathway mutations of splicing machinery in myelodysplasia.,Nature,2018-09-11T20:11:00,478,7367,1964-09-01,Yoshida K et al,doi: 10.1038/nature10496,,0001-09-11,,26842708,Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.,Nature communications,2018-02-04T20:16:00,7,,10615,Alsafadi S et al,doi: 10.1038/ncomms10615,,0001-02-04,,21995386,Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.,The New England journal of medicine,2018-10-13T20:11:00,365,15,1384-95,Papaemmanuil E et al,doi: 10.1056/NEJMoa1103283,,0001-10-13,,21998214,Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.,Blood,2017-12-08T20:11:00,118,24,6239-46,Malcovati L et al,doi: 10.1182/blood-2011-09-377275,,0001-12-08,,25257310,Functional genomics identifies a requirement of pre-mRNA splicing factors for sister chromatid cohesion.,The EMBO journal,2017-11-18T20:14:00,33,22,2623-42,Sundaramoorthy S et al,doi: 10.15252/embj.201488244,,0001-11-18,,17643111,Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.,Nature chemical biology,2018-09-01T20:07:00,3,9,576-83,Kaida D et al,,,0001-09-01,,22150006,SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.,The New England journal of medicine,2017-12-29T20:11:00,365,26,2497-506,Wang L et al,doi: 10.1056/NEJMoa1109016,,2017-12-29T05:06:00,,25892229,SF3B1 association with chromatin determines splicing outcomes.,Cell reports,2018-04-28T20:15:00,11,4,618-29,Kfir N et al,doi: 10.1016/j.celrep.2015.03.048,,0001-04-28,
